当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析

瑞普生物

(300119)

  

流通市值:72.69亿  总市值:100.85亿
流通股本:3.35亿   总股本:4.65亿

瑞普生物(300119)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.91亿元,每股收益0.80元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益515004.28万元,未分配利润201303.84万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产769088.82万元,负债254084.55万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,544,325,031.331,707,587,656.8821,616,475.93,069,933,116.78
营业总成本2,202,944,319.051,464,234,653.83694,874,920.332,690,140,421.73
其他经营收益
营业利润442,271,734.21312,125,190.45137,340,410.3373,167,958.91
利润总额440,509,317.26311,509,253.46135,432,168.8368,289,124.91
净利润390,791,557.17272,063,586.89120,104,766.3329,833,903.18
每股收益
其他综合收益----
综合收益总额390,791,557.17272,063,586.89120,104,766.3329,833,903.18
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,612,103,316.773,701,102,337.823,725,458,129.663,648,969,542.58
非流动资产:
非流动资产合计4,078,784,932.184,253,878,532.194,336,887,061.054,316,823,511.29
资产总计7,690,888,248.957,954,980,870.018,062,345,190.717,965,793,053.87
流动负债:
流动负债合计1,732,829,381.221,999,138,395.072,138,212,045.842,250,828,854.41
非流动负债:
非流动负债合计808,016,106.08864,968,236.98840,596,233.41708,004,141.61
负债合计2,540,845,487.32,864,106,632.052,978,808,279.252,958,832,996.02
所有者权益(或股东权益):
归属于母公司股东权益合计4,673,159,600.714,561,894,007.014,565,978,371.354,469,990,178.39
股东权益合计5,150,042,761.655,090,874,237.965,083,536,911.465,006,960,057.85
负债和股东权益合计7,690,888,248.957,954,980,870.018,062,345,190.717,965,793,053.87
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,018,090,6081,935,001,493.84990,540,979.934,095,851,891.51
经营活动现金流出小计2,812,210,302.781,799,627,801.88917,009,839.793,360,305,684.36
经营活动产生的现金流量净额205,880,305.22135,373,691.9673,531,140.14735,546,207.15
投资活动产生的现金流量:
投资活动现金流入小计2,254,967,689.981,076,066,931.54660,680,833.823,536,719,552.46
投资活动现金流出小计2,194,680,681.971,074,938,614.84755,494,205.523,988,393,222.03
投资活动产生的现金流量净额60,287,008.011,128,316.7-94,813,371.7-451,673,669.57
筹资活动产生的现金流量:
筹资活动现金流入小计889,326,044.79774,941,779.39264,701,382.411,073,222,252.25
筹资活动现金流出小计1,145,081,425.34854,950,006.69269,165,519.111,206,500,773.91
筹资活动产生的现金流量净额-255,755,380.55-80,008,227.3-4,464,136.7-133,278,521.66
汇率变动对现金及现金等价物的影响196,030.85172,814.38163,359.08664,007.64
现金及现金等价物净增加额10,607,963.5356,666,595.74-25,583,009.18151,258,023.56
期末现金及现金等价物余额486,833,827.07532,892,459.28450,642,854.36476,225,863.54
补充资料:
现金及现金等价物的净增加额-56,666,595.74-151,258,023.56
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中金公司王思洋,龙友琪0.871.04--2025-10-28
华安证券王莺,万定宇0.951.101.272025-10-27
国海证券熊子兴,程一胜0.971.131.282025-10-26
财通证券肖珮菁0.961.091.282025-10-26
兴业证券潘江滢,纪宇泽0.981.181.402025-09-10
TOP↑